Eli Lilly (LLY) Partners with Creyon Bio for RNA-Targeted Therapy Development | LLY Stock News

Eli Lilly (LLY, Financial) has entered into a strategic partnership with Creyon Bio, focusing on the innovation and commercialization of RNA-targeted oligonucleotide therapies. This collaboration aims to address various diseases through cut
Read more...